Cost-effectiveness of grass pollen allergen immunotherapy in adults.
Danilo Di BonaMassimo BilanciaMarcello AlbanesiMaria Filomena CaiaffaLuigi MacchiaPublished in: Allergy (2020)
In daily practice, AIT for grass pollens may be a cost-effective option only in patients with low discontinuation rates. SCIT, which is less affected by this limitation than SLIT, seems the most cost-effective AIT form.